PsyBio Therapeutics CorpTSXV:PSYB.HView on Over The Counter Market
- LAST PRICE0.0100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PsyBio Therapeutics Corp | 1.3M | -0.3x | --- |
Revive Therapeutics Ltd | 2.1M | -0.7x | --- |
Psyence Group Inc | 2.1M | 0.0x | --- |
Algernon Pharmaceuticals Inc | 2.2M | -0.4x | --- |
Vaxil Bio Ltd | 1.4M | -12.5x | --- |
Claritas Pharmaceuticals Inc | 974.6K | -0.3x | --- |
Company Information
PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines, and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.
Contact Information
- Headquarters
- 4400 Sample Road; Suite138COCONUT CREEK, FL, United States 33073
- Phone
- 513-449-9585
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Evan Levine
- Chief Financial Officer, Corporate Secretary, Director
- Noah Davis
- Chief Medical Officer
- Michael Spigarelli
- Chief Legal Officer, Director
- Ross Carrmel
- Independent Director
- Nitin Kaushal
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 130.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.03 |
Book Value | $-0.02 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
